IDPH adds bebtelovimab to available COVID-19 treatments
The Illinois Department of Public Health said Tuesday it’s added bebtelovimab to the growing number of monoclonal antibodies available to treat COVID-19.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
